Skip to main content

Table 3 Summary of TEAEs

From: Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: a phase 1 study

Adverse event Participant, n (%) Event, n
Any 15 (75) 22
Any TEAE 15 (75) 22
Mild 15 (75) 21
Moderate 1 (5) 1
Any TRAE 1 (5) 1
Mild 1 (5) 1
  1. TEAE treatment-emergent adverse event; TRAE treatment-related adverse event
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us